Healthcare Asia Magazine

Sector drew $4.4b in 2025 investments, supporting jobs and continued manufacturing expansion.

Hospital-related fees made up 60% of bills and grew faster than doctors’ professional fees, MOH said.

Demand is increasing for long-term dental restorations.

Cheaper generics will compete with branded and pipeline drugs.

System trained on 87,759 patient records exceeds established triage tool in accuracy tests.

The regulatory clearance anchors UltraGreen.ai's Southeast Asia expansion.

Male infertility can be caused by a poor lifestyle, amongst others.

The market is projected to reach $2.81b by 2031, growing annually at 8.44%.

The technology supports clinical applications, including oncology, amongst others.

It will use advanced imaging and cellular‑level immunology tools.

The centre offers non-surgical drug therapies, amongst others. 

Taiwan emerged as a breakout market with a staggering 122.5% growth rate.

GlobalData expects the market to grow at 1% CAGR until 2026.

This signals a growing focus on holistic Parkinson’s disease management.